Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma - MASTER Trial
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2019
At a glance
- Drugs Carfilzomib (Primary) ; Daratumumab (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms MASTER Trial
- 18 Mar 2018 Status changed from not yet recruiting to recruiting.
- 23 Jan 2018 Planned End Date changed from 1 Nov 2023 to 1 Apr 2023.
- 23 Jan 2018 Planned primary completion date changed from 1 Nov 2021 to 1 Apr 2021.